Skip to main content
. Author manuscript; available in PMC: 2018 Apr 24.
Published in final edited form as: Macromol Biosci. 2016 Dec 1;17(5):10.1002/mabi.201600292. doi: 10.1002/mabi.201600292

Figure 6.

Figure 6

Cytotoxicity of OVCAR-3 cells treated with free carboplatin, carboplatin-complexed cRGD-conjugated (T-carboplatin), or cRGD-lacking (NT-carboplatin) unimolecular nanoparticles, and empty nanoparticles (Empty NT and Empty T) for 48 h at two carboplatin concentrations (15 and 30 μg mL−1). *p < 0.05, **p < 0.01.